AMP has announced that it would maintain AXA North and AMP Flexible Super as part of its product and platform plans for the AXA/AMP merger.
AMP’s SignatureSuper would be its medium and large corporate superannuation product, while AMP Flexible Super would target small to medium businesses, the group added.
AMP would continue to invest in its two distinctive insurance offerings — AMP’s Flexible Lifetime Protection and AXA’s Elevate — to ensure they remained competitive, AMP stated. However, within the next two years the company would build a new retail insurance product range that would take the best attributes of the two current offerings.
AMP and AXA’s group risk products would remain, while the group aimed to enhance AMP’s group risk offer that supported AMP’s mastertrust superannuation product and invest in AXA’s stand-alone offer to capitalise on profitable growth opportunities.
Super funds had a “tremendous month” in November, according to new data.
Australia faces a decade of deficits, with the sum of deficits over the next four years expected to overshoot forecasts by $21.8 billion.
APRA has raised an alarm about gaps in how superannuation trustees are managing the risks associated with unlisted assets, after releasing the findings of its latest review.
Compared to how funds were allocated to March this year, industry super funds have slightly decreased their allocation to infrastructure in the six months to September – dropping from 11 per cent to 10.6 per cent, according to the latest APRA data.